vs
Side-by-side financial comparison of Claros Mortgage Trust, Inc. (CMTG) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $46.7M, roughly 1.0× Claros Mortgage Trust, Inc.). STEM, INC. runs the higher net margin — -33.9% vs -468.9%, a 435.0% gap on every dollar of revenue. On growth, STEM, INC. posted the faster year-over-year revenue change (-15.6% vs -22.4%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -10.9%).
Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
CMTG vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.7M | $47.1M |
| Net Profit | $-219.2M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | — | -17.7% |
| Net Margin | -468.9% | -33.9% |
| Revenue YoY | -22.4% | -15.6% |
| Net Profit YoY | -117.7% | 68.8% |
| EPS (diluted) | $-1.56 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.7M | $47.1M | ||
| Q3 25 | $46.1M | $38.2M | ||
| Q2 25 | $51.6M | $38.4M | ||
| Q1 25 | $43.4M | $32.5M | ||
| Q4 24 | $60.2M | $55.8M | ||
| Q3 24 | $64.9M | $29.3M | ||
| Q2 24 | $64.5M | $34.0M | ||
| Q1 24 | $58.8M | $25.5M |
| Q4 25 | $-219.2M | $-16.0M | ||
| Q3 25 | $-9.5M | $-23.8M | ||
| Q2 25 | $-181.7M | $202.5M | ||
| Q1 25 | $-78.6M | $-25.0M | ||
| Q4 24 | $-100.7M | $-51.1M | ||
| Q3 24 | $-56.2M | $-148.3M | ||
| Q2 24 | $-11.6M | $-582.3M | ||
| Q1 24 | $-52.8M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | -468.9% | -33.9% | ||
| Q3 25 | -20.7% | -62.2% | ||
| Q2 25 | -351.9% | 527.8% | ||
| Q1 25 | -181.3% | -76.9% | ||
| Q4 24 | -167.2% | -91.6% | ||
| Q3 24 | -86.7% | -506.3% | ||
| Q2 24 | -17.9% | -1712.6% | ||
| Q1 24 | -89.7% | -283.9% |
| Q4 25 | $-1.56 | $-4.40 | ||
| Q3 25 | $-0.07 | $-2.84 | ||
| Q2 25 | $-1.30 | $-1.79 | ||
| Q1 25 | $-0.56 | $-0.15 | ||
| Q4 24 | $-0.72 | $-15.29 | ||
| Q3 24 | $-0.40 | $-18.24 | ||
| Q2 24 | $-0.09 | $-71.81 | ||
| Q1 24 | $-0.39 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $173.2M | $48.9M |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $1.5B | $-249.4M |
| Total Assets | $4.7B | $308.9M |
| Debt / EquityLower = less leverage | 2.06× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $173.2M | $48.9M | ||
| Q3 25 | $339.5M | $43.1M | ||
| Q2 25 | $209.2M | $40.8M | ||
| Q1 25 | $127.8M | $58.6M | ||
| Q4 24 | $99.1M | $56.3M | ||
| Q3 24 | $113.9M | $75.4M | ||
| Q2 24 | $148.2M | $89.6M | ||
| Q1 24 | $232.5M | $112.8M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $4.0B | — | ||
| Q1 25 | $4.7B | — | ||
| Q4 24 | $4.9B | — | ||
| Q3 24 | $5.1B | — | ||
| Q2 24 | $5.3B | — | ||
| Q1 24 | $5.5B | — |
| Q4 25 | $1.5B | $-249.4M | ||
| Q3 25 | $1.7B | $-235.7M | ||
| Q2 25 | $1.8B | $-214.1M | ||
| Q1 25 | $1.9B | $-417.5M | ||
| Q4 24 | $2.0B | $-398.4M | ||
| Q3 24 | $2.1B | $-344.1M | ||
| Q2 24 | $2.2B | $-203.2M | ||
| Q1 24 | $2.2B | $371.6M |
| Q4 25 | $4.7B | $308.9M | ||
| Q3 25 | $5.4B | $362.6M | ||
| Q2 25 | $5.8B | $379.2M | ||
| Q1 25 | $6.7B | $405.1M | ||
| Q4 24 | $7.0B | $437.4M | ||
| Q3 24 | $7.3B | $537.8M | ||
| Q2 24 | $7.6B | $691.5M | ||
| Q1 24 | $7.8B | $1.3B |
| Q4 25 | 2.06× | — | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | 2.29× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.44× | — | ||
| Q3 24 | 2.44× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | 2.47× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-30.5M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-30.5M | $8.2M | ||
| Q3 25 | $8.8M | $11.4M | ||
| Q2 25 | $-5.8M | $-21.3M | ||
| Q1 25 | $-35.8M | $8.5M | ||
| Q4 24 | $84.5M | $-14.7M | ||
| Q3 24 | $39.2M | $-9.4M | ||
| Q2 24 | $5.5M | $-11.9M | ||
| Q1 24 | $21.5M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMTG
| Real Estate Owned Portfolio | $34.2M | 73% |
| Other | $11.1M | 24% |
| Mixed Use Property Fixed Rents | $1.4M | 3% |
STEM
Segment breakdown not available.
